Kyverna Therapeutics

10/15/2026

Everyday moments can look very different for people living with stiff person syndrome (SPS).

Jocelyn, who lives with SPS, shares how muscle stiffness and spasms can change the smallest parts of daily life, like climbing the stairs. Or how temperature can cause her back to lock up, making each day feel unpredictable. These symptoms are often invisible, but they are always real.

Stories like Jocelyn’s underscore the need for new options for a community with no FDA-approved treatments. These stories, and the people behind them, are at the heart of the work we do every day.

09/21/2026

September is – a chance to talk about something people don't always see when they think about (SPS): pain.

Lauren lives with SPS, and she knows that pain firsthand. It can be debilitating. It can last for hours. It can't be seen, but it's always real.

Her story is one of many that remind us what's at stake for a community still waiting on an FDA-approved treatment. It's stories like hers that drive our work every day.

09/16/2026

Marci's story is being featured in Biotechnology Innovation Organization's campaign, and we couldn't be prouder. Marci was the first person in a U.S. clinical trial to receive CAR T-cell therapy for the treatment of multiple sclerosis (MS). Watch it here: https://fightofourlives.com/stories/marci

Marci lives with MS, a chronic autoimmune disease, and there is a critical need for new therapies that can slow or halt the progressive disability it causes.

Her story also features Kyverna's Dr. Naji Gehchan, who shares how CAR T-cell therapy is designed to reset the immune system with the potential for durable, drug-free, disease-free remission.

We're motivated to redefine the treatment paradigm in neurologic autoimmune diseases – for Marci and everyone like her.

Marci McCue knew something was wrong long before she had a name for it. What started as subtle changes soon became impossible to ignore — her body weakening, simple movements becoming harder, control slipping away in ways she couldn’t explain. Each day brought new uncertainty, and with it, a qui...

09/15/2026

September is .

For people living with Stiff Person Syndrome ( ), pain can be an everyday reality – one that isn’t always visible or understood by others.

Like or share this post to bring more awareness to the realities of living with SPS, and the impact pain can have on everyday life.

08/31/2026

For people living with (MG), every step forward in research matters.

Dr. Ali Habib, a neurologist at University of California, Irvine, shares why clinical trial participation is critical to advancing research and new treatment options for the MG community.

At Kyverna, we’re focused on continuing the momentum of progress for the generalized MG community. Learn more about our gMG clinical trial at: https://www.myastheniagravistrials.com/

08/19/2026

Living with (SPS) means facing muscle stiffness and frequent painful spasms. Today, there are no FDA-approved therapies for this rare, debilitating neurologic autoimmune disease.

Mark knows this reality firsthand. In his own words, he shares what it’s really like living with SPS.

It’s people like Mark who fuel our motivation each day as we work to deliver the potential first FDA-approved treatment for SPS.

06/17/2026

As we recognize and , we’re grateful to Bryan Bosch, leader of the Myasthenia Gravis Association's LGBTQIA+ MG support group, for highlighting the importance of creating spaces where individuals can show up authentically and find support through shared lived experiences.

Progress is fueled not only by scientific innovation, but also by the strength of community. We’re inspired by the MG community every day!

Support groups can help us find connection, community and belonging. Find (MG) support groups here: https://mgassociation.org/support-groups

06/15/2026

06/11/2026

Kyverna is proud to be a sponsor of The Stiff Person Research Foundation’s 2026 Patient Symposium, where we will partner with the Foundation to deliver the “Your Voice, Your Impact” initiative. The goal is simple but powerful: to help people living with stiff person syndrome share their stories and better express how SPS affects their daily lives with those around them.

“We believe every SPS story has the power to create understanding, inspire action, and drive meaningful change, and we’re grateful to have Kyverna’s partnership in bringing this vision to life."

- Neil Mathis, Head of Communications, The Stiff Person Syndrome Research Foundation

We're looking forward to gathering with the community at ! To learn more or attend virtually, visit: https://www.stiffperson.org/2026symposium

06/05/2026

Kyverna’s Sunetra Biswas had the pleasure of recently attending Myasthenia Gravis Foundation of America, Inc. (MGFA)’s San Diego Health Fair, sharing information about our Phase 3 CAR T-cell therapy clinical trial in generalized myasthenia gravis (gMG), KYSA-6.

As we kick off MG Awareness Month, we’re grateful to the MGFA for the opportunity to connect with people living with MG and their caregivers, and to support this incredible community.

Learn more by visiting: https://www.myastheniagravistrials.com/